rs1805006
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM5BP4_StrongBP6BS2
The NM_002386.4(MC1R):c.252C>A(p.Asp84Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00948 in 1,613,160 control chromosomes in the GnomAD database, including 100 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D84?) has been classified as Pathogenic.
Frequency
Consequence
NM_002386.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC1R | ENST00000555147.2 | c.252C>A | p.Asp84Glu | missense_variant | Exon 1 of 1 | 6 | NM_002386.4 | ENSP00000451605.1 | ||
ENSG00000198211 | ENST00000556922.1 | c.252C>A | p.Asp84Glu | missense_variant | Exon 1 of 5 | 2 | ENSP00000451560.1 | |||
MC1R | ENST00000555427.1 | c.252C>A | p.Asp84Glu | missense_variant | Exon 3 of 4 | 5 | ENSP00000451760.1 | |||
MC1R | ENST00000639847.1 | c.252C>A | p.Asp84Glu | missense_variant | Exon 3 of 3 | 5 | ENSP00000492011.1 |
Frequencies
GnomAD3 genomes AF: 0.00533 AC: 811AN: 152256Hom.: 2 Cov.: 33
GnomAD3 exomes AF: 0.00524 AC: 1304AN: 248704Hom.: 7 AF XY: 0.00518 AC XY: 699AN XY: 135010
GnomAD4 exome AF: 0.00992 AC: 14484AN: 1460786Hom.: 98 Cov.: 31 AF XY: 0.00955 AC XY: 6942AN XY: 726628
GnomAD4 genome AF: 0.00532 AC: 811AN: 152374Hom.: 2 Cov.: 33 AF XY: 0.00486 AC XY: 362AN XY: 74508
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:4
The MC1R p.Asp84Glu variant was identified in 15 of 302 proband chromosomes (frequency: 0.0497) from individuals or families with melanoma and was identified in 2 of 298 control chromosomes (frequency: 0.0067) from healthy individuals (Valverde_2016_PMDI:8894704; Matichard_2004_PMID:14757863). The D84E variant has also been associated with red hair and fair skin (Raimondi_2008_PMID:18366057; Beaumont_2007_PMID:17616515). The variant was identified in dbSNP (ID: rs1805006) and ClinVar (classified as benign by Invitae, likely benign by Illumina and likely pathogenic by GeneDx); the variant was not identified in Cosmic or LOVD 3.0. The variant was identified in control databases in 1440 of 280086 chromosomes (7 homozygous) at a frequency of 0.005141 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European (non-Finnish) in 1222 of 127966 chromosomes (freq: 0.009549), Other in 38 of 7140 chromosomes (freq: 0.005322), Latino in 71 of 35352 chromosomes (freq: 0.002008), Ashkenazi Jewish in 20 of 10324 chromosomes (freq: 0.001937), European (Finnish) in 47 of 24950 chromosomes (freq: 0.001884) and African in 42 of 24236 chromosomes (freq: 0.001733), while the variant was not observed in the East Asian or South Asian populations. In vitro expression studies revealed that the D84E variant has reduced cell surface expression and corresponding impairment in cAMP coupling which is associated with the red hair and fair skin pigmentation phenotype (Beaumont_2007_PMID: 17616515). The p.Asp84 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
PS3_supporting, PS4_moderate -
- -
MC1R: PP3, BS2 -
- -
Reported previously in association with increased risk for UV exposure-related melanoma (Puig-Butille et al., 2013; Raimondi et al., 2008); Published functional studies demonstrate a damaging effect: reduced cell surface expression and decreased ability to elevate intracellular cAMP levels (Beaumont et al., 2007); This variant is associated with the following publications: (PMID: 23647022, 11875032, 18366057, 18657399, 22572819, 19924138, 8894704, 26103569, 19656326, 24335900, 17616515, 29405243, 27755135, 30872112, 29795986, 29898205, 30657907, 14757863, 29583157, 29316344, 25159867, 30531825, 31382929, 30414346, 14709592) -
Melanoma, cutaneous malignant, susceptibility to, 5 Benign:2Other:1
- -
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at